Investigation of the correlations between the sleep-wake cycle and pain in an experimental model of fibromyalgia
DOI:
https://doi.org/10.5007/2175-7925.2020.e74455Abstract
Sleep disorders are highly prevalent in patients with fibromyalgia. Many of the daytime symptoms, such as excessive sleepiness and fatigue, can be related to non-restorative sleep patterns and associated with the typical pain conditions of the disease. In this context, we aim to study the possible correlations between the sleep-wake cycle and pain behavior in an animal model of fibromyalgia induced by repeated injections of reserpine. Male and female adult Wistar rats received chronic implants to record EEG and EMG activity. Injections of reserpine produced increases in the response to mechanical stimulation detected using the von Frey test. The reserpine treated rats showed increased incidence of the behavioral states of the sleep-wake cycle with concomitant reduction in the respective durations, showing fragmentation of the cycle. Additionally, the presence of aberrant behaviors was observed in these animals accompanied by notable electroencephalographic changes when compared to control animals. Also noteworthy are changes in specific frequency bands of the EEG corresponding to attentive wakefulness and slow-wave sleep states. Based on these findings, it is possible to infer that the reserpine model of fibromyalgia can be a useful model for this disease in humans.
References
ANDERSEN, M. L.; NASCIMENTO, D. C.; MACHADO, R. B.; ROIZENBLATT, S.; MOLDOFSKY, H.; TUFIK, S. Sleep disturbance induced by substance P in mice. Behavioral Brain Research, Amsterdam, v. 167, n. 2, p. 212-218, 2016.
AVERY, M.C.; KRICHMAR, J.L. Neuromodulatory systems and their interactions: a review of models, theories and experiments. Frontiers in Neural Circuits, New York, v.11, n.118, p.1-18, 2017.
BALCOMBE, J. P.; BARNARD, N. D.; SANDUSKY, C. Laboratory routines cause animal stress. Contemporary Topics in Laboratory Animal Sciences, Memphis, v. 43, n. 6, p. 42-51, 2004.
BASCO-SERRA, A.; ESCRIHUELA-VIDAL, F.; GONZÁLEZ-SOLER, E. M.; MARTÍNEZ-EXPÓSITO, F.; BLASCO-AUSINA, M. C.; MARTÍNEZ-BELLVER, S.; CERVERA-FERRI, A.; TERUEL-MARTÍ, V.; VALVERDE-NAVARRO, A. A. Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats. Physiology & Behavior, Oxford, v. 151. p. 456-462, 2015.
BELLATO, E.; MARINI, E.; CASTOLDI, F.; BARBASETTI, N.; MATTEI, L.; BONASIA, D. E.; BLONNA, D. Fibromyalgia Syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Research and Treatment, London, v. 4, n. 26, p. 1-17, 2012.
BENGTSSON, A.; HENRIKSSON, K. G. The muscle in fibromyalgia-a review of Swedish studies. The Journal of Rheumatology, Toronto, v. 16, n. 19, p. 144-149, 1989.
BERRIDGE, C. W.; SCHMEICHEL, B. E.; ESPAÑA, R. A. Noradrenergic modulation of wakefulness/arousal. Sleep Medicine Reviews, New York, v. 16, p. 187-197, 2012.
BIGATTI, S. M.; HERNANDEZ, A. M.; CRONAN, T. A.; RAND, K. L. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis & Rheumatology, Hoboken, v. 59, p. 961-967, 2008.
BRADLEY, L. A. Pathophysiology of fibromyalgia. American Journal of Medicine, Tucson, v. 122, p. S22-30, 2009.
BUSKILA, D.; SARZI-PUTTINI, P. Genetic aspects of fibromyalgia syndrome. Arthritis Research & Therapy, New York, v. 8, n. 5, p. 218-223, 2006.
CARLI, G.; MONTESANO, A.; RAPEZZI, S.; PALUFFI, G. Differential effects of persistent nociceptive stimulation on sleep stages. Behavioral Brain Research, Amsterdam, v.2 6, n. 2-3, p. 89-98, 1987.
CHERVIN, R. D.; TEODORESCU, M.; KUSHWAHA, R.; DELINE, A. M.; BRUCKSCH, C. B.; RIBBENS-GRIMM, C.; RUZICKA, D. L.; STEIN, P. K.; CLAUW, D. J.; CROFFORD, L. J. Objective measures of disordered sleep in fibromyalgia. The Journal of Reumathology, Toronto, v. 36, n. 9, p. 2009-2016, 2009.
CHOY, E. H. S. The role of sleep in pain and fibromyalgia. Nature Reviews in Rheumatology, Stuttgart, v. 11, p. 513-520, 2015.
CLAUW, D. J. Fibromyalgia: an overview. American Journal of Medicine, Tucson, v. 122, p. S3-S13, 2009.
COLASANTI, B. K.; KOSA, J. E.; CRAIG, C. R. Appearance of wet dog shake behavior during cobalt experimental epilepsy in rat and its suppression by reserpine. Psychopharmacologia, Heidelberg, v. 44, p. 33-36, 1975.
CONSOLI, G.; MARAZZITI, D.; CIAPPARELLI, A.; BAZZICHI, L.; MASSIMETTI, G.; GIACOMELLI, C.; ROSSI, A.; BOMBARDIERI, S.; DELL’OSSO, L. The impact of mood, anxiety, and sleep disorders on fibromyalgia. Comprehensive Psychiatry, Amsterdam, v. l, n. 53, p. 962-967, 2012.
DADABHOY, D.; CLAUW, D. J. Therapy Insight: fibromyalgia – a different type of pain needing a different type of treatment. Nature, New York, v. 2, n. 7, p. 364-372, 2006.
DADABHOY, D.; CROFFORD, L. J.; SPAETH, M.; RUSSELL L. J.; CLAUW, D. J. Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Research & Therapy, New York, v. 8, n. 10, p. 211-228, 2008.
DAMASCENO, F.; SKINNER, G. O.; GOMES, A.; ARAÚJO, P. C.; ALMEIDA, O. M. de Systemic amitriptyline administration does not prevent the increased thermal response induced by paradoxical sleep deprivation. Pharmacology Biochemistry and Behavior, Chilly-Mazarin, v. 9, n. 94-1, p. 51-55, 2009.
DESANTANA, J. M.; CRUZ, K. M. L.; SLUKA, K. A. Animal models of fibromyalgia. Arthritis Research & Therapy, New York, v. 15, p. 222-235, 2013.
DUTY, S.; JENNER, P. Animal models of Parkinson’s disease: a source of novel treatments and clues to the cause of the disease. British Journal of Pharmacology, London, v. 164, n. 4, p. 1357-1391, 2011.
FERREIRA, S. H.; ZANIN, T.; LORENZETTI, B. B.; SOUZA, M. Z. de; MEDEIROS, M. C.; LEME, J. G. Increased vascular permeability, oedema and hyperalgesia caused by carrageenin in the rat’s paw proceedings. Agents Actions, Basel, v. 159, p. 81-92, 1978.
FITZCHARLES, M. A.; STE-MARIE, P. A.; PEREIRA, J. X. Fibromyalgia: evolving concepts over the past 2 decades. Canadian Medical Association Journal, Toronto, v. 185, n. 13, p. 645-651, 2013.
FRANGE, C.; HIROTSU, C.; HACHUL, H.; ARAUJO, P.; TUFIK, S.; ANDERSEN, M. L. Fibromyalgia and sleep in animal models: a current overview and future directions. Current Pain Headache Reports, Berlin, v. 18, n. 8, p. 434-444, 2014.
GOTTESMANN, C. Noradrenaline involvement in basic and higher integrated REM sleep processes. Progress in Neurobiology, Paris, v. 85, p. 237-272, 2008.
GUPTA, A.; MCBETH, J.; MACFARLANE, G. J.; MORRIS, R.; DICKENS, C.; RAY, D.; CHIU, Y. H.; SILMAN, A. J. Pressure pain thresholds and tender point counts as predictors of new chronic widespread pain in somatising subjects. Annals of the Rheumatic Diseases, London, v. 66, n. 4, p. 517-521, 2007.
HAMILTON, N. A.; AFFLECK, G.; TENNEN, H.; KARLSON, C.; LUXTON, D.; PREACHER, K. J.; TEMPLIN, J. L. Fibromyalgia: the role of sleep in affect and in negative event reactivity and recovery. Health Psychology, Washington, v. 27, n. 4, p. 490-497, 2008.
HARTMAN, E. Reserpine: its effect on the sleep-dream cycle in man. Psychopharmacologia, Heidelberg, v. 9, p. 242-246, 1966.
HERNANDEZ-LEON, A.; FERNANDEZ-GUÁSTI, A.; MARTÍNEZ, A.; PELLICER, F.; GONZÁLEZ-TRUJANO, M. E. Sleep architecture is altered in the reserpine-induced fibromyalgia model in ovariectomized rats. Behavioral Brain Research, Amsterdam, v. 364, p. 383-392, 2019.
HOFFMAN, J. S.; DOMINO, E. F. Comparative effects of reserpine on the sleep cycle of man and cat. Journal of Pharmacology and Experimental Therapeutics, Bethesda, v. 170, n. 2, p. 190-198, 1969.
HORNE, J. A.; SHACKELL, B. S. Alpha like-activity in non-REM sleep and the fibromyalgia (fibrositis) syndrome. EEG Clinical Neurophysiology, New York, v. 79, n. 4, p. 271-276, 1991.
HUNSLEY, M. S.; PALMITER, R. D. Norepinephrine-Deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine. Sleep, Oxford, v. 26, n. 5, p. 521-526, 2003.
JAIMCHARIYATAM, N.; RODRIGUEZ, C. L.; BUDUR, K. Prevalence and correlates of alpha-delta sleep in Major Depressive Disorders. Innovations in Clinical Neuroscience, West Chester, v. 8, n. 7, p. 35-49, 2011.
JONES, C. K.; EASTWOOD, B. J.; NEED, A. B.; SHANNON, H. E. Analgesic effects of serotoninergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotoninergic and noradrenergic reuptake inhibition. Neuropharmacology, Amsterdam, v. 51, v. 7-8, p. 1172-1180, 2006.
KATZ, D. L.; GREENE, L.; ALI, A.; FARIDI, Z. The pain of fibromyalgia is due to muscle hypoperfusion induced by regional vasomotor dysregulation. Medical Hypotheses, Amsterdam, v. 69, n. 3, p. 517-525, 2007.
KNIGHT, T.; SCHAEFER, C.; CHANDRAN, A.; ZLATEVA, G.; WINKELMANN, A.; PERROT, S. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoeconomics and Outcomes Research, Macclesfield, v. 5, p. 171-80, 2013.
KUWANA, S. The effects of reserpine and serpetin on the EEG in rabbits. Folia Pharmacologica Japonica, Tokyo, v. 52, n. 3, p. 317-321, 1956.
LEGOFF, P. Is Fibromyalgia a muscle disorder? Joint Bone Spine, Amsterdam, v. 73, n. 3, p. 239-242, 2006.
LEYS, L. J.; CHU, K. L.; XU, J.; PAI, M.; Yang, H. S.; ROBB, H. M.; JARVIS, M. F.; RADEK, R. J.; MCGARAUGHTY, S. Disturbances in slow-wave sleep are induced by models of bilateral inflammation, neuropathic, and postoperative pain, but not osteoarthritic pain in rats. Pain, Washington, v. 154, n. 7, p. 1092-1102, 2013.
MACHADO, R. B.; HIPÓLIDE, D. C.; BENEDITO-SILVA, A. A.; TUFIK, S. Sleep deprivation induced by modified multiple platform technique: quantification of sleep loss and recovery. Brain Research, Amsterdam, v. 1004, n. 1-2, p. 45-51, 2004.
MCCARBERG, B. H. Clinical overview of fibromyalgia. American Journal of Therapeutics, Alphen aan den Rijn, v. 19, n. 5, p. 357-368, 2012.
MOCHIZUCHI, D. Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Human Psychopharmacology, Hoboken, v. 9, Suppl. 1, p. S15-19, 2004.
MOLDOFSKY, H. Rheumatic pain modulation syndrome: the interrelationships between sleep, central nervous system serotonin and pain. Advances in Neurology, Minneapolis, v. 33, p. 51-57, 1981.
MOLDOFSKY, H. The significance of the dysfunctions of the sleep-waking brain to the pathogenesis and treatment of fibromyalgia syndrome. Rheumatic Disease Clinics of North America, Amsterdam, v. 35, n. 2, p. 275-283, 2009.
MOLDOFSKY, H.; SCARISBRICK, P.; ENGLAND, R.; SMYTHE, H. Musculoskeletal symptoms and NonREM sleep disturbance in patients with ‘fibrositis syndrom’ and healthy subjects. Psychosomatic Medicine, Hoboken, v. 37, n. 4, p. 341-351, 1975.
MONTI, J. M. Serotonin control of sleep-wake behavior. Sleep Medicine Reviews, New York, v. 15, p. 269-281, 2011.
MONTI, J. M.; MONTI, D. The involvement of dopamine in the modulation of sleep and waking. Sleep Medicine Reviews, New York, v. 11, p. 113-133, 2007.
NABESHIMA, T.; YAMAGUCHI, K.; YOSHIDA, S.; FURUKAWA, H.; KAMEYAMA, T. Phencyclidine-induced wet-dog shakes observed in rats after withdrawal from reserpine treatment. Pharmacology Biochemistry and Behavior, Chilly-Mazarin, v. 24, n. 5, p. 1275-1279, 1986.
NAGAKURA, Y.; OE, T.; AOKI, T.; MATSUOKA, N. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia. Pain, Washington, v. 146, n. 1-2, p. 26-33, 2009.
NAGAKURA, Y.; TAKAHASHI, M.; NOTO, T.; SEKIZAWA, T.; OE, T.; YOSHIMI, E.; TAMAKI, K.; SHIMIZU, Y. Different pathophysiology underlying animal models of fibromyalgia and neuropathic pain: comparison of reserpine-induced myalgia and chronic constriction injury in rats. Behavioral Brain Research, Amsterdam, v. 226, p. 242-249, 2012.
NAKAZAWA, S.; NAKAMICHI, K.; IMAI, H.; ICHIHARA, J. Effect of dopamine D4 receptor agonists on sleep architecture in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry, Quebec, v. 63, n. 3, p. 6-13, 2015.
NAUTIYAL, K. M.; HEN, R. Serotonin receptors in depression: from A to B. F1000 Research, London, v. 6, n. 123, p. 1-12, 2017.
NIELSEN, L. A.; HENRIKSSON, K. G. Pathophysiologic mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition. Best Practice & Research: Clinical Rheumatology, Amsterdam, v. 21, n. 3, p. 465-480, 2007.
NIEUWENHUYS, R.; DONKELAAR, H. J. T.; NICHOLSON, C. The Central Nervous System of Vertebrates. Vol. 3. Berlin: Springer, 1998. 960 p.
PAXINOS, G.; WATSON, C. The rat brain in stereotaxic coordinates. San Diego: Academic Press, 1997. 209 p.
PEREIRA, R. P.; FACHINETTO, R.; PRESTES, A. S.; WAGNER, C.; SUDATI, J. H.; BOLIGON, A. A.; ATHAYDE, M. L; MORSCH, V. M.; ROCHA, J. B. T. Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats. Journal of Neural Transmission, New York, v. 118, n. 11, p. 1547-1557, 2011.
PORTAS, C. M.; BJORVATN, B.; URSIN, R. Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Progress in Neurobiology, Paris, v. 60, p. 13-35, 2000.
QUEIRÓZ, L. P. Worldwide epidemiology of fibromyalgia. Current Pain Headache Reports, New York, v. 17, n. 8, p. 356-361, 2013.
RUSSELL, I. J.; VAEROY, H.; JAVORS, M.; NYBERG, F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis & Rheumatology, London, v. 35, p. 550-556, 1992.
SCHULDINER, S.; SHIRVAN, A.; LINIAL, M. Vesicular neurotransmitter transporters: from bacteria to humans. Physiological Reviews, Washington, v. 75, n. 2, p. 369-392, 1995.
SIMMS, R. W. Is there muscle pathology in Fibromyalgia Syndrome? Rheumatic Disease Clinics of North America, Amsterdam, v. 22, n. 2, p. 245-266, 1996.
SPAETH, M.; RIZZI, M. Fibromyalgia and sleep. Best Practice & Research Clinical Rheumatology, Amsterdam, v. 25, p. 227-239, 2011.
TIMO-IARIA, C.; NEGRÃO, N.; SCHMIDEK, W.; ROCHA, T. L.; HOSHINO, K. Phases and states of sleep in the rat. Physiology & Behavior, Oxford, v. 5, p. 402-407, 1970.
VAN TWYVER, H. Sleep patterns of five rodent species. Physiology & Behavior, Oxford, v. 4, p. 901-905, 1969.
WOLFE, F.; CLAUW, D. J.; FITZCHARLES, M. A.; GOLDENBERG, D. L.; HÄUSER, W.; KATZ, R. S.: MEASE, P.; RUSSELL, A. S.; RUSSELL, I. J.; WINFIELD, J. B. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. The Journal of Rheumatology, Toronto, v. 38, n. 6, p. 1113-1122, 2011.
ZEILHOFER, H. U.; MÖHLER, H.; DI LIO, A. GABAergic analgesia: new insights from mutant mice and subtype-selective agonists. Cell, London, v. 30, n. 8, p. 397-402, 2009.
ZHEN-YONG, G.; YANG, P.; QING-JUN, H.; HAI-YUN, X. The influence of dizocilpine on the reserpine-induced behavioral and neurobiological changes in rats. Neuroscience Letters, London, v. 614, p. 89-94, 2016.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Camila Naumann Pereira, Beatriz Ferreira Nunes, Edison Sanfelice André
This work is licensed under a Creative Commons Attribution 4.0 International License.
After the electronic publication of the manuscript, the authors are entitled, without any restriction, on its contents.
License Creative Commons Atribuição 4.0 Internacional - CC BY
Authors are able to take on additional contracts separately, non-exclusive distribution of the version of the paper published in this journal (ex.: publish in institutional repository or as a book), with an acknowledgment of its initial publication in this journal.
